5Vote!
Market Wire (Free subscription) | 10/05/2009
XI'AN, CHINA (MARKET WIRE) Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company will present at the 2009 Roth Capital Partners China Conference on Wednesday, October 14, 2009 at 10:00 a.m. Eastern time. The...
5Vote!
Market Wire (Free subscription) | 09/24/2009
XI'AN, CHINA (MARKET WIRE) Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it has begun manufacturing and distributing its Health Protection Series line consisting of three new products designed to improve nutrition...
5Vote!
Market Wire (Free subscription) | 10/13/2009
... with growth prospects in China. Presenters include TPG clients Lihua International, Inc. and Skystar Bio-Pharmaceutical Company. "This is the 9th ROTH Capital Partners event that The Piacente Group has sponsored over the past several years," said Brandi Piacente, President of TPG. "Since recently expanding our portfolio of representation in China to include new NASDAQ issues Lihua International...
5Vote!
The Street (Free subscription) | 10/12/2009
This Chinese biopharm play is seriously undervalued, but investors and analysts are stating to take notice.
